Hidrox^® Counteracts Cyclophosphamide-Induced Male Infertility through NRF2 Pathways in a Mouse Model

• Main Authors: Roberta Fusco (Author), Angela Trovato Salinaro (Author), Rosalba Siracusa (Author), Ramona D'Amico (Author), Daniela Impellizzeri (Author), Maria Scuto (Author), Maria Laura Ontario (Author), Roberto Crea (Author), Marika Cordaro (Author), Salvatore Cuzzocrea (Author), Rosanna Di Paola (Author), Vittorio Calabrese (Author)
• Format: Book
• Published: MDPI AG, 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Every year, men use cyclophosphamide to treat various cancers and autoimmune diseases. On the one hand, this chemotherapy often has the beneficial effect of regressing the tumor, but on the other hand, it leads to infertility due to excessive oxidative stress and apoptosis in the testes...